Equities

Par Drugs and Chemicals Ltd

Par Drugs and Chemicals Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (INR)243.70
  • Today's Change9.10 / 3.88%
  • Shares traded28.96k
  • 1 Year change+32.19%
  • Beta1.0988
Data delayed at least 15 minutes, as of Sep 20 2024 11:21 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of INR
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
ASSETS
Cash And Short Term Investments367222162
Total Receivables, Net185212217
Total Inventory426047
Prepaid expenses--0.43--
Other current assets, total2.81--9.07
Total current assets596494436
Property, plant & equipment, net413387344
Goodwill, net------
Intangibles, net------
Long term investments0.120.100.10
Note receivable - long term01.500
Other long term assets6.415.767.65
Total assets1,016889787
LIABILITIES
Accounts payable5481107
Accrued expenses------
Notes payable/short-term debt000
Current portion long-term debt/capital leases--0--
Other current liabilities, total715942
Total current liabilities124140149
Total long term debt000
Total debt000
Deferred income tax353536
Minority interest------
Other liabilities, total01.404.06
Total liabilities160176188
SHAREHOLDERS EQUITY
Common stock123123123
Additional paid-in capital--107--
Retained earnings (accumulated deficit)733483476
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total------
Total equity856712599
Total liabilities & shareholders' equity1,016889787
Total common shares outstanding121212
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.